Mutual Funds – Mutual Funds Investing - Investment Mutual Funds BETA

Eaton Vance WW Health Sciences A (ETHSX)

General Information  As of 11/20/2009 NAV $8.57 NAV Daily Change ($0.04) % Yield 0 % SEC Yield N/A % YTD Return (as of 09/30/2009) 9.31 Objective* Equity - Sector Health Peer* HL * Key Portfolio Statistics % Unrealized Gain YTD -5.43 Net Assets (Mil $) 05/31/2009 686.86 % Turnover 05/31/2009 48.00 Fees % Max Sales Load 5.75 % Min Sales Load .00 % Max Deferred Load .00 Expenses % Max 12b-1 Fee .25 % Max Management Fee 1.00 % Redemption Fee 1.00 % Expense Ratio 2.06 Allocation Large Growth 39.03 Large Value .00 Small Growth .00 Small Value .00 Foreign Stock .00 Emerging Market .00 Precious Metals .00 Intermediate Bond 24.21 Foreign Bond .00 High Yield Bond .00 Portfolio Information Composition As of 05/31/2009 % of Net Assets Stock 96.51 Cash .00 Bonds .00 Preferred .00 Convertibles 1.54 Foreign Stock 25.78 Foreign Bonds .00 Hedge .00 Other 1.94 Sector / Country Weightings Sector / Country Weightings As of 05/31/2009 % of Portfolio Health 57.85 Services 14.83 Industrial Cyclical 11.14 Other 10.89 Retail Trade 3.23 Technology 2.06 N/A N/A N/A N/A N/A N/A Portfolio Holdings Top Equity Holdings (As of 05/31/2009) % of Portfolio Value (Mil$) BIOGEN IDEC INCORPORATED 4.68 51.79 SHIONOGI & CO LTD 4.45 49.32 WYETH 4.25 47.10 GENZYME CORPORATION 4.01 44.36 BRISTOL-MYERS SQUIBB COMPANY 3.96 43.82 GILEAD SCIENCES INCORPORATED 3.89 43.10 ROCHE HOLDING AG 3.26 36.15 COVIDIEN LIMITED 3.23 35.72 MERCK KGAA 3.20 35.39 N/A N/A N/A

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Funds over the next 6 months. Zacks Rank Definition #1 Strong Buy #2 Buy #3 Hold #4 Sell #5 Strong Sell S&P 500 Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Rank Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place Zacks Premium - The only way to get access to the Zacks Rank Zacks Premium Research - NEW! Zacks Mutual Fund Rank    Find similar funds that have a Mutual Fund Rank. Find Similar Funds Now  Fund Description The fund was incepted in July 1985 and is managed by Boston Management and Research. The objective of the fund is to seek long-term capital growth by investing in a global and diversified portfolio of health sciences companies. The fund pursues its objective by investing in worldwide health sciences portfolio. The fund invests primarily in common stocks of companies engaged in the development, production or distribution of products related to scientific advances in health care and companies with a broad range of market capitalization's, including small companies. The fund offers dividends and capital gains annually. Stock Holding Statistics  % of Net Assets As Of 05/31/2009 Total Issues 41 Avg. P/E 29.18 Avg. P/Book 5.92 Avg. EPS Growth 8.35 Avg. Market Value (Mil $) 27,279 Risk 3 Year 5 Year 10 Year Beta 0.58 0.60 0.62 Alpha 4.87 2.06 9.00 R Squared 0.43 0.39 0.26 Std. Dev. 17.42 15.10 19.83 Sharpe -0.04 0.03 3.00 Shareholder Information Manager Team Managed Since N/A Manager Rating * SEE EXPLANTION N/A Inception Date 07/26/1985 Shareholders 43,033 Dividends Paid A Minimum Initial Investment $1,000 Minimum Subsequent Investment $0 IRA Minimum $0 IRA Available Y Check Writing N Phone Invest Y Phone Exchange Y Phone Redeem Y Auto Invest Y Wire Redeem N Wire Fee N Wire Transfer N Contact Information Family Eaton Vance Address The Eaton Vance Bldg, 255 State St Boston, MA 02109 Phone 800 262-1122